415 related articles for article (PubMed ID: 26724575)
21. Targeting the IDO1/TDO2-KYN-AhR Pathway for Cancer Immunotherapy - Challenges and Opportunities.
Cheong JE; Sun L
Trends Pharmacol Sci; 2018 Mar; 39(3):307-325. PubMed ID: 29254698
[TBL] [Abstract][Full Text] [Related]
22. Bisphenol F exposure induces depression-like changes: Roles of the kynurenine metabolic pathway along the "liver-brain" axis.
Yu Z; Lin Y; Wu L; Wang L; Fan Y; Xu L; Zhang L; Wu W; Tao J; Huan F; Liu W; Wang J; Gao R
Environ Pollut; 2024 Apr; 346():123356. PubMed ID: 38266696
[TBL] [Abstract][Full Text] [Related]
23. Regulation of the kynurenine metabolism pathway by Xiaoyao San and the underlying effect in the hippocampus of the depressed rat.
Wang J; Li X; He S; Hu L; Guo J; Huang X; Hu J; Qi Y; Chen B; Shang D; Wen Y
J Ethnopharmacol; 2018 Mar; 214():13-21. PubMed ID: 29217494
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of kynurenine pathway metabolism in Toxoplasma gondii-infected mice: implications for schizophrenia.
Notarangelo FM; Wilson EH; Horning KJ; Thomas MA; Harris TH; Fang Q; Hunter CA; Schwarcz R
Schizophr Res; 2014 Jan; 152(1):261-7. PubMed ID: 24345671
[TBL] [Abstract][Full Text] [Related]
25. The kynurenine pathway contributes to long-term neuropsychological changes in experimental pneumococcal meningitis.
Too LK; McQuillan JA; Ball HJ; Kanai M; Nakamura T; Funakoshi H; McGregor IS; Hunt NH
Behav Brain Res; 2014 Aug; 270():179-95. PubMed ID: 24844751
[TBL] [Abstract][Full Text] [Related]
26. Depressive symptoms as a side effect of Interferon-α therapy induced by induction of indoleamine 2,3-dioxygenase 1.
Murakami Y; Ishibashi T; Tomita E; Imamura Y; Tashiro T; Watcharanurak K; Nishikawa M; Takahashi Y; Takakura Y; Mitani S; Fujigaki H; Ohta Y; Kubo H; Mamiya T; Nabeshima T; Kim HC; Yamamoto Y; Saito K
Sci Rep; 2016 Jul; 6():29920. PubMed ID: 27436416
[TBL] [Abstract][Full Text] [Related]
27. Chronic Treatment with the IDO1 Inhibitor 1-Methyl-D-Tryptophan Minimizes the Behavioural and Biochemical Abnormalities Induced by Unpredictable Chronic Mild Stress in Mice - Comparison with Fluoxetine.
Laugeray A; Launay JM; Callebert J; Mutlu O; Guillemin GJ; Belzung C; Barone PR
PLoS One; 2016; 11(11):e0164337. PubMed ID: 27828964
[TBL] [Abstract][Full Text] [Related]
28. Young Plasma Induces Antidepressant-Like Effects in Aged Rats Subjected to Chronic Mild Stress by Suppressing Indoleamine 2,3-Dioxygenase Enzyme and Kynurenine Pathway in the Prefrontal Cortex.
Ghaffari-Nasab A; Badalzadeh R; Mohaddes G; Javani G; Ebrahimi-Kalan A; Alipour MR
Neurochem Res; 2022 Feb; 47(2):358-371. PubMed ID: 34626305
[TBL] [Abstract][Full Text] [Related]
29. The inhibition of the kynurenine pathway prevents behavioral disturbances and oxidative stress in the brain of adult rats subjected to an animal model of schizophrenia.
Réus GZ; Becker IRT; Scaini G; Petronilho F; Oses JP; Kaddurah-Daouk R; Ceretta LB; Zugno AI; Dal-Pizzol F; Quevedo J; Barichello T
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():55-63. PubMed ID: 29030243
[TBL] [Abstract][Full Text] [Related]
30. Indoleamine 2,3 Dioxygenase as a Potential Therapeutic Target in Huntington's Disease.
Mazarei G; Leavitt BR
J Huntingtons Dis; 2015; 4(2):109-18. PubMed ID: 26397892
[TBL] [Abstract][Full Text] [Related]
31. Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs.
Volarevic V; Markovic BS; Jankovic MG; Djokovic B; Jovicic N; Harrell CR; Fellabaum C; Djonov V; Arsenijevic N; Lukic ML
Theranostics; 2019; 9(20):5976-6001. PubMed ID: 31534532
[TBL] [Abstract][Full Text] [Related]
32. Activation of indoleamine 2, 3- dioxygenase pathway by olanzapine augments antidepressant effects of venlafaxine in mice.
Thomas J; Khanam R; Vohora D
Psychiatry Res; 2017 Dec; 258():444-448. PubMed ID: 28911850
[TBL] [Abstract][Full Text] [Related]
33. Thymoquinone Loaded Solid Lipid Nanoparticles Demonstrated Antidepressant-Like Activity in Rats via Indoleamine 2, 3- Dioxygenase Pathway.
Alam M; Zameer S; Najmi AK; Ahmad FJ; Imam SS; Akhtar M
Drug Res (Stuttg); 2020 May; 70(5):206-213. PubMed ID: 32198742
[TBL] [Abstract][Full Text] [Related]
34. Kynurenic acid and 3-hydroxykynurenine production from D-kynurenine in mice.
Wang XD; Notarangelo FM; Wang JZ; Schwarcz R
Brain Res; 2012 May; 1455():1-9. PubMed ID: 22498176
[TBL] [Abstract][Full Text] [Related]
35. Activation of Brain Indoleamine-2,3-dioxygenase Contributes to Depressive-Like Behavior Induced by an Intracerebroventricular Injection of Streptozotocin in Mice.
Souza LC; Jesse CR; de Gomes MG; Del Fabbro L; Goes ATR; Donato F; Boeira SP
Neurochem Res; 2017 Oct; 42(10):2982-2995. PubMed ID: 28631232
[TBL] [Abstract][Full Text] [Related]
36. Non-tumor cell IDO1 predominantly contributes to enzyme activity and response to CTLA-4/PD-L1 inhibition in mouse glioblastoma.
Zhai L; Ladomersky E; Dostal CR; Lauing KL; Swoap K; Billingham LK; Gritsina G; Wu M; McCusker RH; Binder DC; Wainwright DA
Brain Behav Immun; 2017 May; 62():24-29. PubMed ID: 28179106
[TBL] [Abstract][Full Text] [Related]
37. Investigation of the kynurenine pathway in Indoleamine 2, 3 dioxygenase deficient mice with inflammatory arthritis.
Kolodziej L
Transgenic Res; 2013 Oct; 22(5):1049-54. PubMed ID: 23417792
[TBL] [Abstract][Full Text] [Related]
38. Genetic Deficiency of Indoleamine 2,3-dioxygenase Aggravates Vascular but Not Liver Disease in a Nonalcoholic Steatohepatitis and Atherosclerosis Comorbidity Model.
Arora A; Tripodi GL; Kareinen I; Berg M; Forteza MJ; Gisterå A; Griepke S; Casagrande FB; Martins JO; Abdalla DSP; Cole J; Monaco C; Ketelhuth DFJ
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563591
[TBL] [Abstract][Full Text] [Related]
39. Acute Psychological Stress Modulates the Expression of Enzymes Involved in the Kynurenine Pathway throughout Corticolimbic Circuits in Adult Male Rats.
Vecchiarelli HA; Gandhi CP; Hill MN
Neural Plast; 2016; 2016():7215684. PubMed ID: 26819772
[TBL] [Abstract][Full Text] [Related]
40. Exhaustion of CD4+ T-cells mediated by the Kynurenine Pathway in Melanoma.
Rad Pour S; Morikawa H; Kiani NA; Yang M; Azimi A; Shafi G; Shang M; Baumgartner R; Ketelhuth DFJ; Kamleh MA; Wheelock CE; Lundqvist A; Hansson J; Tegnér J
Sci Rep; 2019 Aug; 9(1):12150. PubMed ID: 31434983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
